HQ Pharma (Shanghai) Co., Ltd. – FDA Inspection, Nov 8, 2023

Record Details

This FDA Inspection record concerns HQ Pharma (Shanghai) Co., Ltd., with an inspection on November 8, 2023, issued by the Office of Inspections and Investigations.

Company: HQ Pharma (Shanghai) Co., Ltd.
Inspection Date: November 8, 2023
Office: Office of Inspections and Investigations
Person: Kevin P. Regan (FDA Associated Person)

View Company Profile

ID · 5b19d392-ee65-46aa-8767-de5c801ba507

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1223658
FDA center: Human Drugs
Outcome: Form 483 issued

FDA Citations

21 CFR 211.22(c)Approve or reject procedures or specs

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore HQ Pharma (Shanghai) Co., Ltd.

FDA Inspection

HQ Pharma (Shanghai) Co., Ltd.November 8, 2023